New IFPMA and EFPIA guidance on use of social media by the p...

On 28 September 2022, the international and European self-regulatory bodies for the research-based pharmaceutical industry (I

New study reveals patients’ changing needs during COVID-19

New research from The Patients Association, supported through sponsorship provided by Novo Nordisk and

Education as the solution to the rare disease ‘diagnostic od...

It took more than a year for Don Legere to receive a diagnosis of scleroderma, a rare disease that causes the skin and connective tissues to thicken and harden, robbing people of their jobs and

BMS launches digital Advocacy Exchange for patient groups af...

Bristol Myers-Squibb and digital health firm GRYT Health have teamed up to develop an ‘Advocacy Exchange’ virtual platform to unite patient advocacy organisations, patients, policy makers,

Industry and patient groups collaborate on new guidance for ...

Why pharma isn’t collaborating with patient organisations as...

Patient centricity has rapidly gone from a fringe idea to a fundamental principle across the industry, but are pharma companies missing out on more impactful patient engagement through part